The Carrier Science Behind “Natural Flavour” — and Why Glycerin Isn’t the Villain
Share
By Dr. Eugene Capitano, DC, MSc
“Natural flavour” is a legal term, not an ingredient list. Behind those two words can sit a formulation of flavouring substances, carriers, solvents and processing aids that may not be individually named on the finished label. The useful question is not simply whether a carrier exists. It is which carrier was used, what the evidence says about it and whether the manufacturer tells you it is there.
That distinction matters because ingredients with similar-sounding names can behave very differently—and because substances often treated as inactive are not always biologically inert.
Glycerin and glyceryl stearate are not the same ingredient
Put two names side by side: glycerin and glyceryl stearate. They share part of a name, but they are chemically and functionally different.
Glycerin—also called glycerol—is a small molecule used as a humectant and solvent. It holds water and helps keep extracts stable. It does not have a fatty-acid tail and does not behave as an emulsifying detergent. At high oral doses it can have an osmotic, stool-loosening effect, but that is a tolerance issue and should not be confused with evidence of gut-barrier damage at flavouring amounts.
Glyceryl stearate is an ester: glycerol with a fatty acid attached. That structure gives it surfactant properties, allowing it to sit at fat–water interfaces. The biological effects of glycerol, glyceryl stearate and other glycerol esters therefore need to be evaluated separately. A shared word in their names does not make them interchangeable.
Is maltodextrin biologically inert?
Maltodextrin is a starch-derived, digestible carbohydrate widely used as a bulking agent and as a carrier in some powdered flavour preparations. It has also frequently been used as an oral placebo or control carbohydrate in clinical research.
A 2022 systematic review examined 70 randomized placebo-controlled trials in which maltodextrin was used as the oral placebo or control. The authors classified 42 of the 70 trials—60%—as reporting physiological, microbial-metabolite or gut-microbiome effects attributed to maltodextrin. Reported findings included changes in microbial composition, microbial metabolites, immune or inflammatory markers and measures of gut function or permeability.
That result deserves attention, but it also needs context. The direction of the reported changes was inconsistent, and the dose, delivery form, duration and populations varied substantially between studies. The review therefore challenges the assumption that maltodextrin is always an inactive placebo. It does not establish that maltodextrin produces one predictable effect, that it harms everyone or that the small amount potentially supplied by a flavour carrier is equivalent to the amounts used in those trials.
A terminology note: this discussion concerns ordinary digestible maltodextrin used as a bulking agent or carrier. Resistant maltodextrin is a different, fibre-like ingredient and should not automatically be assigned the same physiological effects.
What laboratory and animal studies add
In an ex vivo experiment, researchers maintained a human-derived gut microbial community in a MiniBioReactor Array and exposed it to 20 commonly used food additives with emulsifying properties. Numerous—but not all—additives altered microbial density, composition, gene expression or inflammatory potential. Maltodextrin was among the compounds associated with some changes that persisted after exposure ended. This was a laboratory model of human microbiota, not a trial in people, and the study did not establish maltodextrin as the single strongest compound tested.
Preclinical work has raised additional questions about the intestinal mucus barrier. In colitis-prone mice, maltodextrin exposure was associated with fewer mucus-containing cells, closer proximity of bacteria to the intestinal epithelium and earlier or more severe colitis. In primary intestinal epithelial cultures derived from those mice, maltodextrin also reduced mucus-secreting cell numbers and mucus area in the absence of microbes or immune cells. These findings support further investigation, but they cannot be transferred directly to ordinary human consumption.
Other cell and mouse studies have reported increased adhesion of Crohn’s disease-associated Escherichia coli to intestinal cells and increased survival or colonization of Salmonella after maltodextrin exposure. Again, these are mechanistic and preclinical findings—not evidence that a serving of flavoured protein causes infection or inflammatory bowel disease.
What the evidence does—and does not—mean
It does not mean that every natural flavour contains maltodextrin. Flavour systems differ. It does not mean that a scoop of flavoured protein causes colitis, and it does not prove that trace exposure harms any particular person.
The narrower conclusion is more defensible: maltodextrin is not reliably inert across the published evidence, while its long-term effects at the small and variable amounts contributed by flavour preparations remain uncertain.
Maltodextrin is not nutritionally necessary for our formula. We therefore chose a different approach—not because every use of maltodextrin has been proven harmful, but because we could build the flavour without it and disclose every component instead.
The ethanol footnote
Vanilla extract is traditionally made with ethanol. Ethanol is volatile and much of it can evaporate during drying or heating, but “cooks off completely” is too absolute. At the same time, there is no evidence that the very small residual amount potentially contributed by a flavouring damages the human gut barrier. We avoid ethanol for a simpler formulation reason: when an alcohol-free extract meets our standard, it removes an unnecessary variable.
Our actual Heritage Vanilla standard
It is not “no carrier, ever.” A liquid vanilla extract needs a suitable material to become a stable, evenly dispersed powder. The meaningful distinction is between an unnamed carrier and a fully disclosed one selected for the formula.
Heritage Vanilla Bean Spice uses an alcohol-free vanilla extract made from whole vanilla pods infused in water and food-grade vegetable glycerine. We carry that extract on acacia fibre rather than maltodextrin, then add ground whole vanilla bean—with visible seeds—and Ceylon cinnamon. Every component is named. Nothing is hidden behind the words “natural flavour.”
Why we assemble that system instead of buying a conventional flavour preparation is its own story: We Couldn't Buy a Clean Vanilla. So We Built Our Own.
“Natural” should be a conclusion you reach after seeing what is inside—not a word you are asked to take on faith.
Want the short version? Read “Natural Vanilla Flavour” Sounds Clean. But What Is Actually Inside?
References
- Almutairi R, Basson AR, Wearsh P, Cominelli F, Rodriguez-Palacios A. Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo-controlled clinical trials. European Journal of Nutrition. 2022;61(6):2853–2871.
- Naimi S, Viennois E, Gewirtz AT, Chassaing B. Direct impact of commonly used dietary emulsifiers on human gut microbiota. Microbiome. 2021;9:66.
- Zangara MT, et al. Maltodextrin consumption impairs the intestinal mucus barrier and accelerates colitis through direct actions on the epithelium. Frontiers in Immunology. 2022;13:841188.
- Nickerson KP, McDonald C. Crohn’s disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS ONE. 2012;7(12):e52132.
- Nickerson KP, et al. The dietary polysaccharide maltodextrin promotes Salmonella survival and mucosal colonization in mice. PLoS ONE. 2014;9(7):e101789.
This article is educational and is not medical advice. Individual responses to foods vary, and the experimental doses and models discussed here do not establish the effect of the amount that might be present in any particular finished food.
DISCLOSURE
Dr. Eugene Capitano is Co-Founder and Scientific Lead of TLC PureOrigin™ and Founder of TLC NeuroMicrobiome Labs Inc. This commercial relationship should be considered when evaluating commentary about protein products, ingredients and formulation.
Dr. Capitano earned an MSc in Psychology & Neuroscience of Mental Health from King’s College London. He holds the ACSM Exercise is Medicine® Credential and is an ACSM Certified Personal Trainer®.
By Dr. Eugene Capitano, DC, MSc
Dr. Eugene Capitano earned an MSc in Psychology & Neuroscience of Mental Health from King’s College London. He holds the ACSM Exercise is Medicine® (EIM) Credential and is an ACSM Certified Personal Trainer® (ACSM-CPT®). His research interests include the gut–brain axis, functional nutrition, metabolic health, and translational microbiome science.